As shown in Figure 4A, NB and AVM tissue expressed similarly lower levels of SMAD4 mRNA compared to CCMs, consistent with the previously reported activated TGF‐β signaling in CCM tissue.17, 18. The gene discussed is SMAD4; the disease is neuroblastoma.